Pembrolizumab (anti-PD-1) Synonyms: MK-3475, lambrolizumab Cat.No.A2005 Purity:99%
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0452072
- Awardee
- Selleck Chem LLC
- Contracting organization
- University of Virginia
- Cumulative value
- $977.00
About this award
The University of Virginia awarded contract A207_PO-0452072 to Selleck Chem LLC on June 25, 2026, for the procurement of pharmaceutical research materials. The contract encompasses a single line item for Pembrolizumab (anti-PD-1), a monoclonal antibody immunotherapy agent also known by the synonyms MK-3475 and lambrolizumab, with catalog number A2005 and 99% purity specification. One unit of the product is being delivered to Xinghua Liao under this award.
The total contract value is $977, representing a nominal procurement consistent with laboratory research or clinical trial support activities. No separate annual value or contract period information is provided in the award documentation. As a Virginia-based contracting activity, the University of Virginia serves as the procuring organization for this specialized pharmaceutical supply contract with prime contractor Selleck Chem LLC.
Line items
| Item | Total |
|---|---|
| Pembrolizumab (anti-PD-1) Synonyms: MK-3475, lambrolizumab Cat.No.A2005 Purity:99% | $977.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0452072?
Contract A207_PO-0452072 was awarded to Selleck Chem LLC by University of Virginia on June 25, 2026.
How much is contract A207_PO-0452072 worth?
Its cumulative value is $977.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award